{
    "code": "02025557",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025557",
    "time": "2017-04-21 03:28:08",
    "許可證字號": "衛署藥輸字第025557號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/02\/22",
    "發證日期": "105\/02\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202555701",
    "中文品名": "可利新注射液0.1毫克\/毫升",
    "英文品名": "GLYPRESSIN 0.1mg\/ml Solution for Injection",
    "適應症": "出血性食道靜脈曲張，第一型肝腎症候群。",
    "劑型": "270注射劑",
    "包裝": "8.5毫升安瓿瓶裝 5安瓿盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "TERLIPRESSINACETATE"
    ],
    "限制項目": "",
    "申請商名稱": "1509801100  輝凌藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F490014100  ZENTIVA K.S.",
        "製造廠廠址": "U kabelovny 130, 102 37 Praha 10, Dolni Mecholupy, Czech Republic",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6828001120",
            "成分名稱": "TERLIPRESSIN ACETATE",
            "含量描述": "Terlipressin free base 0.1MG (corresponding to 0.118MG Terlipressin acetate)",
            "含量": "0.0000000000",
            "單位": ""
        }
    ],
    "仿單外盒": [
        {
            "title": "可利新注射液_仿單-106-01-16.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025557&Seq=002&Type=9"
        },
        {
            "title": "020255570001-105-04-13.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025557&Seq=002&Type=8"
        },
        {
            "title": "020255570001-105-04-13.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025557&Seq=001&Type=8"
        }
    ]
}